FDA Approved: SYNAREL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved a supplemental application for Synarel (nafarelin acetate) submitted by Pfizer Laboratories Div Pfizer Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Precocious Puberty
• Endometriosis

Drugs mentioned

• Synarel (nafarelin acetate)

Snippet

SUPPL AP for SYNAREL (NAFARELIN ACETATE)